…SV}} ] Interpretation : Qp/Qs 1.5 : Significant left to right shunt (e.g., large ASD/VSD). Qp/Qs < 0.7 : Significant right to left…

…of acute aortic syndromes, IMH for approximately 10%–20%, and PAU for about 5%; reported proportions vary by population and region. Intramural haematoma IMH is…

…the clinical value of any diagnostic test depends not only on its sensitivity and specificity but also on disease prevalence in the population being tested…

…reversible causes should be pursued (Table 2). Figure 1. Management of acute bradycardia in the emergency setting. Parameter Assessment A Airway Voice Breath sounds B…

…and an undiluted syringe of 10 mg/mL makes small adjustments impossible. Procedure Intravenous titration in acute severe pain Practical points during titration: Give the…

…most common class of major congenital malformations. CHD occurs in approximately 1% of live births, and 10% of aborted fetuses, with no significant geographical variations…

…with reported prevalence ranging from 18% to 52%. They frequently occur in patients with severe coronary artery disease, defined in the source material as stenosis…

…clinical syndrome characterized by the cardinal symptoms and signs of heart failure (HF) in the presence of a left ventricular ejection fraction (LVEF) of ≥50…

…4 cm may enlarge by approximately 1.5–2 mm per year, whereas larger aneurysms generally expand more rapidly. Rapid enlargement is defined in the…

…acute heart failure in which an ischaemic or cardiometabolic cause is suspected. Selected asymptomatic individuals in whom coronary disease is detected incidentally or during cardiovascular…

…CAC findings incidentally identified on a chest CT performed for another indication can also contribute to risk assessment. Visual reporting of coronary calcification using four…

…Stephen et al.). Figure 1 illustrates the decline in cardiopulmonary function and consciousness with decreasing body temperature. There appears to be a linear relationship between…

…Failure with improved Ejection Fraction" (HFimpEF) is now applied to patients with a baseline LVEF ≤40% who have experienced a ≥10 point increase in LVEF…